Attached files
| file | filename |
|---|---|
| EX-3.1 - EXHIBIT 3.1 - OZOP ENERGY SOLUTIONS, INC. | ozsc0206form8kexh3_1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 21, 2020
OZOP SURGICAL CORP.
(Exact name of registrant as specified in its charter)
| Nevada | 000-55976 | 35-2540672 |
| (State
or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification Number) |
319 Clematis Street Suite 714 West Palm Beach FL 33401
(Address of principal executive offices, including zip code)
(866) 286-1055
(Registrant’s telephone number, including area code)
Not applicable.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☑
| ☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On February 7, 2020, the Financial Industry Regulatory Authority (“FINRA”) announced the registrant’s 1:1,000 reverse stock split of the registrant’s common stock. The reverse stock split will take effect on February 10, 2020, with FINRA changing the registrant’s ticker symbol to “OZSCD” for 20 business days (after which time the symbol will revert back to “OZSC”). The registrant filed a Certificate of Amendment – Certificate to Accompany Amended and Restated Articles of Incorporation (the “Amended and Restated Articles of Incorporation”) with the State of Nevada, adding a paragraph to registrant’s Articles of Incorporation to effect the reverse stock split.
The foregoing description of the Amended and Restated Articles of Incorporation is qualified in its entirety by reference to the Amended and Restated Articles of Incorporation, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description |
| 3.1* | Amended and Restated Articles of Incorporation |
| • | Filed herein |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 7, 2020
OZOP SURGICAL CORP.
By: /s/ Barry Hollander
Barry Hollander
Chief Financial Officer